HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study.

AbstractBACKGROUND:
Some antibiotic agents, including cotrimoxazole, inhibit the metabolism of warfarin sodium and possibly increase the risk of hemorrhage. We examined the risk of upper gastrointestinal (UGI) tract hemorrhage in older patients receiving warfarin in combination with antibiotics commonly used to treat urinary tract infection, with a focus on cotrimoxazole.
METHODS:
This population-based, nested case-control study using health care databases in Ontario, Canada, between April 1, 1997, and March 31, 2007, identified residents 66 years or older who were continuously treated with warfarin. Cases were hospitalized with UGI tract hemorrhage. For each case, we selected up to 10 age- and sex-matched control subjects. We calculated adjusted odds ratios (aORs) for exposure to cotrimoxazole, amoxicillin trihydrate, ampicillin trihydrate, ciprofloxacin hydrochloride, nitrofurantoin, and norfloxacin within 14 days before the UGI tract hemorrhage.
RESULTS:
We identified 134 637 patients receiving warfarin, of whom 2151 cases were hospitalized for UGI tract hemorrhage. Cases were almost 4 times more likely than controls to have recently received cotrimoxazole (aOR, 3.84; 95% confidence interval [CI], 2.33-6.33). Treatment with ciprofloxacin was also associated with increased risk (aOR, 1.94; 95% CI, 1.28-2.95), but no significant association was observed with amoxicillin or ampicillin (1.37; 0.92-2.05), nitrofurantoin (1.40; 0.71-2.75), or norfloxacin (0.38; 0.12-1.26). Compared with amoxicillin or ampicillin, cotrimoxazole prescription was associated with an almost 3-fold risk (ratio of ORs, 2.80; 95% CI, 1.48-5.32).
CONCLUSIONS:
Among older patients receiving warfarin, cotrimoxazole is associated with a significantly higher risk of UGI tract hemorrhage than other commonly used antibiotics. Whenever possible, clinicians should prescribe alternative antibiotics in patients receiving warfarin.
AuthorsHadas D Fischer, David N Juurlink, Muhammad M Mamdani, Alexander Kopp, Andreas Laupacis
JournalArchives of internal medicine (Arch Intern Med) Vol. 170 Issue 7 Pg. 617-21 (Apr 12 2010) ISSN: 1538-3679 [Electronic] United States
PMID20386005 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Infective Agents, Urinary
  • Anticoagulants
  • Warfarin
  • Ampicillin
  • Amoxicillin
  • Trimethoprim, Sulfamethoxazole Drug Combination
Topics
  • Aged
  • Aged, 80 and over
  • Amoxicillin (adverse effects)
  • Ampicillin (adverse effects)
  • Anti-Infective Agents, Urinary (adverse effects)
  • Anticoagulants (adverse effects)
  • Case-Control Studies
  • Databases, Factual
  • Drug Interactions
  • Drug Therapy, Combination
  • Female
  • Gastrointestinal Hemorrhage (chemically induced)
  • Humans
  • Male
  • Multivariate Analysis
  • Odds Ratio
  • Ontario
  • Trimethoprim, Sulfamethoxazole Drug Combination (adverse effects)
  • Urinary Tract Infections (drug therapy)
  • Warfarin (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: